Global Yeast Beta-Glucan Market

Yeast Beta-Glucan Market Size, Share, Growth Analysis, By Source (Grains & Cereal, Mushroom), By Category (Insoluble, Soluble), By Application (Food & Beverages, Personal Care & Cosmetics), By Region - Industry Forecast 2026-2033

Report ID: SQMIG30I2298 | Region: Global | Published Date: December, 2025
Pages: 198 |Tables: 64 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Yeast Beta-Glucan Market size was valued at USD 218.3 Million in 2024 and is poised to grow from USD 236.86 Million in 2025 to USD 454.91 Million by 2033, growing at a CAGR of 8.5% during the forecast period (2026–2033). 

    Global Yeast Beta-Glucan Market is highly competitive with the presence of several key players. These players are focusing on product innovation, partnerships, mergers and acquisitions, and expansion to increase their market share and stay competitive in the market. For instance, in December 2021, Lallemand Inc. entered into a partnership with Biotalys NV, a biotech company, to develop and commercialize new biocontrol solutions for food and beverage applications. Such strategic initiatives are expected to drive the growth of the yeast beta-glucan market in the coming years. 'Lesaffre (France) ', 'Kerry Group PLC (Ireland) ', 'Tate & Lyle PLC (UK) ', 'DSM-Firmenich (Switzerland) ', 'Merck (US) ', 'Kemin Industries (US) ', 'Alltech (US) ', 'Lallemand Inc. (Canada) ', 'Leiber GmbH (Germany) ', 'Associated British Foods Plc (UK) ', 'Angel Yeast Co., Ltd. (China) ', 'Ceapro Inc. (Canada) ', 'Specialty Biotech Co., Ltd. (US) ', 'Garuda International Inc. (US) ', 'Biotec Pharmacon (Norway) ', 'NutraQ AS (Norway) ', 'Tateyama Kagaku Group (Japan) ', 'AIDP Inc. (US) ', 'Ohly (Germany)'

    One of the key drivers of the yeast beta-glucan market is the increasing demand for natural and organic food products. Consumers are becoming more health-conscious and are looking for natural and effective ways to improve their health. Yeast beta-glucan is a natural ingredient that is effective in promoting health and wellness, making it a popular choice among consumers. For instance, in 2020, Kellogg Company, an American multinational food manufacturing company, launched a new line of cereals containing beta-glucan sourced from oats and barley to meet the growing demand for natural and healthy food products.

    Growing Trend of Plant-Based Diets: The growing trend of plant-based diets is driving the growth of the yeast beta-glucan market. Consumers are becoming more health-conscious and are opting for plant-based diets due to the health and environmental benefits associated with them. Yeast beta-glucan is a natural and plant-based ingredient, making it a popular choice among consumers who are following plant-based diets.

    The global yeast beta-glucan market is dominated by North America, which is expected to hold a 35% share of the market in the coming years. This dominance is attributed to the increasing demand for natural and functional food ingredients, along with the rising health consciousness among consumers in the region. The United States is a major contributor to the growth of the yeast beta-glucan market in North America. The country has a large population of health-conscious consumers who are willing to pay a premium for natural and effective health solutions. For instance, companies like Biothera Pharmaceuticals, Inc. have developed and launched yeast beta-glucan-based dietary supplements in the US market, which has received a positive response from consumers.

    Related Reports

    Yeast Market
    Buy Now GET FREE SAMPLE
    Yeast Ingredients Market
    Buy Now GET FREE SAMPLE
    Fungal Protein Market
    Buy Now GET FREE SAMPLE
    Torula Yeast Market
    Buy Now GET FREE SAMPLE
    Yeast Extracts For Animal Feed Market
    Buy Now GET FREE SAMPLE
    Glycolic Acid Market
    Buy Now GET FREE SAMPLE
    Neopentyl Glycol Market
    Buy Now GET FREE SAMPLE
    Beta-Carotene Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Yeast Beta-Glucan Market

    Report ID: SQMIG30I2298

    $5,300
    BUY NOW